Role of integrin α(v)β3 in vascular biology

Thrombosis and Haemostasis

Volumn 80, Issue 5, 1998, Pages 726-734

  Byzova, Tatiana V ^a   Rabbani, Ramin ^a   D'Souza, Stanley E ^a   Plow, Edward F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; LIGAND; PROTEIN SUBUNIT;

ANGIOGENESIS; ARTERY INTIMA PROLIFERATION; BIOLOGY; BLOOD VESSEL; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

EID: 0031744346     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615250     Document Type: Review

References (138)

1. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990; 75: 1383-95.
2. Dana N, Clayton LK, Tennen DG, Pierce MW, Lachmann PJ, Law SA, Arnaout MA. Leukocytes from four patients with complete or partial leuCAM deficiency contain the common β-subunit precursor and β-subunit messenger RNA. J Clin Invest 1987; 79: 1010-5.
3. Von Andrian UH, Berger EM, Ramezani L, Chambers JD, Ochs HD, Harlan JM, Paulson JC, Etzioni A, Arfors K-E. In vivo behavior of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndromes. J Clin Invest 1993; 91: 2893-7.
4. Dresner-Pollack R, Rosenblatt M. Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporsis. J Cell Biochem 1994; 56: 323-30.
5. 3, in melanoma metastasis. Cancer Metastasis Rev 1995; 14: 241-52.
6. Cheresh DA. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 1987; 84: 6471-5.
7. Charo IF, Bekeart LS, Phillips DR. Platelet glycoprotein IIb-IIIa-like proteins mediate endothelial cell attachment to adhesive proteins and the extracellular matrix. J Biol Chem 1987; 262: 9935-8.
8. Dejana E, Languino LR, Colella S, Corbascio GC, Plow E, Ginsberg M, Marchisio PC. The localization of a platelet Gp IIb-IIIa-related protein in endothelial cell adhesion structures. Blood 1988; 71: 566-72.
9. Conforti G, Dominguez-Jimenez C, Zanetti A, Gimbrone MA, Jr., Cremona O, Marchisio PC, Dejana E. Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood 1992; 80: 437-46.
10. Lampugnani MG, Resnati M, Dejana E, Marchisio PC. The role of integrins in the maintenance of endothelial monolayer integrity. J Cell Biol 1991; 112: 479-90.
11. Glass WF, II, Kreisberg JI. Regulation of integrin-mediated adhesion at focal contacts by cyclic AMP. J Cell Physiol 1993; 157: 296-306.
12. Swerlick RB, Brown EJ, Xu Y, Lee KH, Manos S, Lawley TJ. Expression and modulation of the vitronectin receptor on human dermal microvascular endothelial cells. J Invest Dermatol 1992; 99: 715-22.
13. 3) is implicated, in cooperation with P-selectin and platelet-activating factor, in the adhesion of monocytes to activated endothelial cells. Biochem J 1994; 304: 537-42.
14. Enenstein J, Waleh NS, Kramer RH. Basic FGF and TGF-beta differentially modulate integrin expression of human microvascular endothelial cells. Exp Cell Res 1992; 203: 499-503.
15. Brown SL, Lundgren CH, Nordt T, Fujii S. Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis. Cardiovasc Res 1994; 28: 1815-20.
16. 3 integrin expression in normal and atherosclerotic artery. Circ Res 1995; 77: 1129-35.
17. Krissansen GW, Lucas CM, Stomski FC, Elliott MJ, Berndt MC, Boyd AW, Horton MA, Cheresh DA, Vadas MA, Burns GF. Blood leukocytes bind platelet glycoprotein (IIb-IIIa) but do not express the vitronectin receptor. Int Immunol 1990; 2: 267-77.
18. Savill J, Dransfield I, Hogg N, Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 1990; 343: 170-3.
19. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149: 4029-35.
20. De Nichilo MO, Burns GF. Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate αv integrin expression on cultured human macrophages. Proc Natl Acad Sci USA 1993; 90: 2517-21.
21. Moulder K, Roberts K, Shevach EM, Coligan JE. The mouse vitronectin receptor is a T cell activation antigen. J Exp Med 1991; 173: 343.
22. Roberts K, Yokoyama WM, Kehn PJ, Shevach EM. The vitronectin receptor serves as an accessory molecule for the activation of a subset of gamma/δ T cells. J Exp Med 1991; 173: 231-40.
23. Roberts K, Shevach EM. Immunoregulatory role of gammaδ T cells. Ann N Y Acad Sci 1991; 636: 1-8.
24. Sturmhofel K, Brando C, Martinon F, Shevach EM, Coligan JE. Antigen-independent, integrin-mediated T cell activation. J Immunol 1995; 154: 2104-11.
25. 2+-and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature 1995; 377: 75-9.
26. Carreno M-P, Gresham HD, Brown EJ. Isolation of leukocyte response integrin: a novel RGD-binding protein involved in regulation of phagocytic function. Clin Immunol Immunopathol 1993; 69: 43-51.
27. Fitzgerald LA, Poncz M, Steiner B, Rall SC, Jr., Bennett JS, Phillips DR. Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor alpha-subunits and platelet glycoprotein IIb. Biochemistry 1987; 26: 8158-65.
28. Fitzgerald LA, Charo IF, Phillips DR. Human and bovine endothelial cells synthesize membrane proteins similar to human platelet glycoproteins IIb and IIIa. J Biol Chem 1985; 260: 10893-6.
29. Pytela R, Pierschbacher MD, Ruoslahti E. A 125/115-kDA cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. Proc Natl Acad Sci USA 1985; 83: 5766-70.
30. Suzuki S, Argraves WS, Pytela R, Arai H, Kruisius T, Pierschbacher MD, Ruoslahti E. cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc Natl Acad Sci USA 1986; 83: 8614-8.
31. 3. J Biol Chem 1994; 269: 4641-7.
32. 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science 1990; 249: 915-8.
33. 58Co(III). J Biol Chem 1991; 266: 11429-32.
34. Fitzgerald LA, Steiner B, Rall SC, Jr., Lo SS, Phillips DR. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. J Biol Chem 1987; 262: 3936-9.
35. D'Souza SE, Haas TA, Piotrowicz RS, Byers-Ward V, McGrath DE, Soule HR, Cierniewski CS, Plow EF, Smith JW. Ligand and cation binding are dual functions of a discrete segment of the integrin beta-3 subunit: cation displacement from this site is implicated in ligand binding. Cell 1994; 79: 659-67.
36. 3 subunit. J Biol Chem 1996; 271: 21978-84.
37. 1 subunit. J Biol Chem 1996; 271: 20438-43.
38. 5 subunits contain a metal ion-dependent adhesion site-like motif but lack an I domain. J Biol Chem 1997; 272: 14236-43.
39. 3-(GPIIb-IIIa) tyrosine phosphorylation induced by platelet aggregation. J Biol Chem 1996; 271: 10811-5.
40. O'Toole TE, Ylanne J, Culley BM. Regulation of integrin affinity states through an NPXY motif in the β subunit cytoplasmic domain. J Biol Chem 1995; 270: 8553-8.
41. 3: a ternary complex of the integrin α and β subunits and a divalent cation. J Biol Chem 1996; 271: 6017-26.
42. Felding-Habermann B, Cheresh DA. Vitronectin and its receptors. Curr Opin Cell Biol 1993; 5: 864-8.
43. 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol 1990; 111: 2795-800.
44. 3 integrin receptor complexes to attach to laminin. J Cell Biol 1990; 111: 1233-43.
45. Lawler J, Weinstein R, Hynes RO. Cell attachment to thrombospondin: The role of arg-gly-asp, calcium and integrin receptors. J Cell Biol 1988; 107: 2351-61.
46. 3 receptor. Blood 1993; 82: 3622-30.
47. 1 integrins. J Cell Sci 1993; 105: 1001-12.
48. 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem 1991; 266: 20369-74.
49. Horton MA, Taylor ML, Arnett TR, Helfrich MH. Arg-gly-asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res 1991; 195: 368-75.
50. Pfaff M, Aumailley M, Specks U, Knolle J, Zerwes H-G, Timpl R. Integrin and arg-gly-asp dependence of cell adhesion to the native and unfolded triple helix of collagen type VI. Exp Cell Res 1993; 206: 167-76.
51. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491-7.
52. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Biol 1996; 12: 697-715.
53. Cherny RC, Honan MA, Thiagarajan P. Site-directed mutagenesis of the arginine-glycine-aspartic acid in vitronectin abolishes cell adhesion. J Biol Chem 1993; 268: 9725-9.
54. Beacham DA, Wise RJ, Turci SM, Handin RI. Selective inactivation of the arg-gly-asp-ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis. J Biol Chem 1992; 267: 3409-15.
55. 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA 1994; 91: 8856-60.
56. Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT. The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res 1996; 224: 344-53.
57. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA. Regulation of integrin function by the urokinase receptor. Science 1996; 273: 1551-5.
58. 5-directed cell migration. J Biol Chem 1996; 271: 29393-9.
59. Salonen E-M, Vaheri A, Pollanen J, Stephens R, Andreasen P, Mayer M, Dano K, Gailit J, Ruoslahti E. Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. J Biol Chem 1989; 264: 6339-43.
60. 3 binding to vitronectin. Nature 1996; 383: 441-3.
61. Seiffert D, Loskutoff DJ. Type 1 plasminogen activator inhibitor induces multimerization of plasma vitronectin. A suggested mechanism for the generation of the tissue form of vitronectin in vivo. J Biol Chem 1996; 271: 29644-51.
62. Miles LA, Ginsberg MH, White JG, Plow EF. Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest 1986; 77: 2001-9.
63. 3. Cell 1996; 85: 683-93.
64. Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 1998; 92: 391-400.
65. Scarborough RM, Rose JW, Hsu MA, Phillips DR, Fried VA, Campbell AM, Nannizzi L, Charo IF. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus M. Barbouri. J Biol Chem 1991; 266: 9359-62.
66. 3. J Biol Chem 1995; 270: 9917-25.
67. 3 and osteopontin expression during neointima formation. Cardiovasc Res 1998; 36: 408-28.
68. Lundgren CH, Sawa H, Fujii S. Inhibition of neointimal hyperplasia after balloon injury by local delivery of a cyclic arginine-glycine-aspartic acid peptide targeting vitronectin receptor [Abstract]. J Am Coll Cardiol 1995; 25: 83.
69. 1 integrins. J Biol Chem 1994; 269: 20233-8.
70. Lam SC-T, Plow EF, Smith MA, Andrieux A, Ryckwaert J-J, Marguerie G, Ginsberg MH. Evidence that arginine-glycine-aspartic acid and fibrinogen gamma chain peptides share a common binding site on platelets. J Biol Chem 1987; 262: 947-50.
71. 3 and glycoprotein IIb-IIIa with fibrinogen. J Biol Chem 1990; 265: 12267-71.
72. 3-mediated melanoma cell adhesion to fibrinogen and its plasmic fragments. J Biol Chem 1992; 267: 5070-7.
73. Cheresh DA, Berliner SA, Vicente V, Ruggeri ZM. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 1989; 58: 945-53.
74. 3-integrins. J Biol Chem 1994; 269: 960-7.
75. 3 function through integrin-associated protein. J Cell Biol 1996; 135: 533-44.
76. Smith JW, Cheresh DA. The Arg-Gly-Asp binding domain of the vitronectin receptor. J Biol Chem 1988; 263: 18726-31.
77. D'Souza SE, Ginsberg MH, Lam SC-T, Plow EF. Chemical cross-linking of arsinyl-glycyl-aspartic acid peptides to an adhesion receptor on platelets. J Biol Chem 1988; 263: 3943-51.
78. 3. J Biol Chem 1996; 271: 2033-9.
79. Savage B, Ruggeri ZM. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets. J Biol Chem 1991; 266: 11227-33.
80. Gartner TK, Amrani DL, Derrick JM. Characterization of adhesion of nonexogenously stimulated and resting platelets in normal plasma to fibrinogen and its fragments. Blood Coagul Fibrinolysis 1994; 5: 747-54.
81. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: Emerging paradigms of signal transduction. Annu Rev Cell Biol 1995; 11: 549-99.
82. Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64: 1393-401.
83. Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979; 254: 5357-63.
84. 1: Regulation of the functional response by soluble fibronectin. J Cell Biol 1993; 121: 155-62.
85. Conforti G, Zanetti A, Pasquali-Ronchetti I, Quaglino D, Jr., Neyroz P, Dejana E. Modulation of vitronectin receptor binding by membrane lipid composition. J Biol Chem 1990; 265: 4011-9.
86. Buchanan MR, Bertomeu MC, Haas TA, Orr FW, Eltringham-Smith LL. Localization of 13-hydroxyoctadecadienoic acid and the vitronectin receptor in human endothelial cells and endothelial cell/platelet interactions in vitro. Blood 1993; 81: 3303-12.
87. Zanetti A, Conforti G, Hess S, Martìn-Padura I, Ghibaudi E, Preissner KT, Dejana E. Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membrane. Blood 1994; 84: 1116-23.
88. 3 on platelets and lymphocytes binds to the matrix protein osteopontin. J Biol Chem 1997; 272: 8137-40.
89. 3. J Cell Biol 1998; 141: 1685-95.
90. Shattil SJ, Ginsberg MH. Perspective Series: Cell adhesion in vascular biology. Integrin signaling in vascular biology. J Clin Invest 1997; 100: S91-S5.
91. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 1993; 120: 577-85.
92. fak in platelets. J Cell Biol 1992; 119: 905-12.
93. FAK in platelets requires coordinated signaling through integrin and agonist receptors. J Biol Chem 1994; 269: 14738-45.
94. 3 through cytoskeletal reorganization and tyrosine phosphorylation in human platelets. J Biol Chem 1995; 270: 11927-34.
95. Furman MI, Grigoryev D, Bray PF, Dise KR, Goldschmidt-Clermont PJ. Platelet tyrosine kinases and fibrinogen receptor activation. Circ Res 1994; 75: 172-80.
96. Jackson SP, Schoenwaelder SM, Yuan YP, Salem HH, Cooray P. Nonreceptor protein tyrosine kinases and phosphatases in human platelets. Thromb Haemost 1996; 76: 640-50.
97. 3. EMBO J 1997; 16: 6414-25.
98. 3 avidity. J Biol Chem 1997; 272: 28757-61.
99. Schwartz MA. Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium. J Cell Biol 1993; 120: 1003-10.
100. Shanker S, Davison I, Mason WT, Horton MA. Integrin receptor mediated mobilization of intranuclear calcium in rat osteoclasts. J Cell Sci 1993; 105: 61-8.
101. Schwartz MA, Brown EJ, Fazeli B. A 50-kDa integrin-associated protein is required for integrin-regulated calcium entry in endothelial cells. J Biol Chem 1993; 268: 19931-4.
102. Cooper D, Lindberg FP, Gamble JR, Brown EJ, Vadas MA. The transendothelial migration of neutrophils involves integrin associated protein (CD47). Proc Natl Acad Sci USA 1995; 92: 3978-82.
103. v Integrins mediate the rise in intracellular calcium in endothelial cells on fibronectin even though they play a minor role in adhesion. J Biol Chem 1994; 269: 11133-7.
104. 3 integrins on the cell surface during mitosis. J Cell Biochem 1996; 61: 338-49.
105. Brooks PC. Cell adhesion molecules in angiogenesis. Cancer Metastasis Rev 1996; 15: 187-94.
106. 3 during angiogenesis. J Clin Invest 1996; 98: 426-33.
107. 3 for angiogenesis. Science 1994; 264: 569-71.
108. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79: 1157-64.
109. 3 integrin associates with a 190-kDa protein that is phosphorylated on tyrosine in response to platelet-derived growth factor. J Biol Chem 1993; 268: 17270-6.
110. 3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF. EMBO J 1997; 16: 5600-7.
111. 3 integrin mediate enhanced tyrosine phosphorylation of multiple proteins in adherent bovine pulmonary artery endothelial cells. J Biol Chem 1996; 270: 16781-7.
112. v integrin cytoplasmic tail. J Biol Chem 1996; 271: 31458-62.
113. src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 1993; 120: 1417-26.
114. Wary KK, Mainiero F, Isakoff SJ, Marcantonio EE, Giancotti FG. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell 1996; 87: 733-43.
115. Ginsberg MH, Loftus J, Ryckwaert J-J, Pierschbacher M, Pytela R, Ruoslahti E, Plow EF. Immunochemical and amino-terminal sequence comparison of two cytoadhesins indicates they contain similar or identical beta subunits and distinct alpha subunits. J Biol Chem 1987; 262: 5437-40.
116. 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 1995; 95: 713-24.
117. Matsuno H, Stassen JM, Moons L, Vermylen J, Hoylaerts MF. Neointima formation in injured hamster carotid artery is effectively prevented by the combination G4120 and quinapril. Thromb Haemost 1996; 76: 263-9.
118. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994; 74: 214-24.
119. 3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surg 1994; 19: 125-34.
120. 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 1993; 121: 163-70.
121. 3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor I. Proc Natl Acad Sci USA 1996; 93: 2482-7.
122. Matsuno H, Stassen JM, Vermylen J, Decktnyn H. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation 1994; 90: 2203-6.
123. vβ3 in a guinea pig model of restenosis [Abstract]. Circulation 1996; 94: I-517.
124. vβ3 integrin reduces neointimal thickening in a balloon-injured rabbit iliac artery [Abstract]. Circulation 1996; 94: I-257.
125. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, Sigmon K, Anderson KM, Lee KL, Willerson JT. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months. Lancet 1994; 343: 881-6.
126. Tcheng JE, Harrington RA, Kottke-Marchant K, Kleiman NS, Ellis SG, Kereiakes DJ, Mick MJ, Navetta FI, Smith JE, Worley SJ, Miller JA, Joseph DM, Sigmon KN, Kitt MM, du Mee CP, Califf RM, Topol EJ. Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators. Circulation 1995; 91: 2151-7.
127. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336: 1689-96.
128. v integrins. Science 1995; 270: 1500-2.
129. Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nature Med 1996; 2: 529-33.
130. 3 integrin knockout mice display a Glanzmann thrombasthenia phenotype [Abstract]. Blood 1997; 90: 2550a.
131. vβ3 integrin in mediating fibrin gel retraction. J Biol Chem 1995; 270: 1785-90.
132. vβ3. Blood 1995; 86: 2606-15.
133. vβ3 integrin mediates arteriolar vasodilation in response to RGD peptides. Circ Res 1996; 79: 821-6.
134. Winocour PD, Richardson M, Kinlough-Rathbone RL. Continued platelet interaction with de-endothelialized aortae associated with slower re-endothelialization and more extensive intimai hyperplasia in spontaneously diabetic BB Wistar rats. Int J Exp Pathol 1993; 74: 603-13.
135. Maxfield SR, Moulder K, Koning F, Elbe A, Stingl G, Coligan JE, Shevach EM, Yokoyama WM. Murine T cells express a cell surface receptor for multiple extracellular matrix proteins. Identification and characterization with monoclonal antibodies. J Exp Med 1989; 169: 2173-90.
136. Lam SC, Plow EF, D'Souza SE, Cheresh DA, Frelinger AL, III, Ginsberg MH. Isolation and characterization of a platelet membrane protein related to the vitronectin receptor. J Biol Chem 1989; 264: 3742-9.
137. Coller BS, Cheresh DA, Asch E, Seligsohn U. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood 1991; 77: 75-83.
138. vβ3 on vascular cells during wound repair. Am J Pathol 1996; 148: 1407-21.